CSIMarket
 
Pacific Booker Minerals Inc   (PBM)
Other Ticker:  
 
    Sector  Basic Materials    Industry Metal Mining
   Industry Metal Mining
   Sector  Basic Materials
 
Price: $1.2900 $-0.30 -18.868%
Day's High: $1.54 Week Perf: -27.12 %
Day's Low: $ 1.25 30 Day Perf: 88.32 %
Volume (M): 2,338 52 Wk High: $ 4.31
Volume (M$): $ 3,016 52 Wk Avg: $1.10
Open: $1.40 52 Wk Low: $0.51



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -1
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Pacific Booker Minerals Inc
Pacific Booker Minerals Inc is a Canadian mining company that focuses on exploring and developing mineral properties. The company is primarily focused on its Morrison copper-gold project located in British Columbia, Canada. Pacific Booker Minerals is committed to responsible and sustainable mining practices, which includes working closely with local communities and adhering to strict environmental regulations. The company is dedicated to maximizing shareholder value through the efficient exploration and development of its mineral properties.


   Company Address: Suite #1203 - 1166 Alberni Street Vancouver 0 BC
   Company Phone Number:    Stock Exchange / Ticker: PBM
   PBM is expected to report next financial results on May 31, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Clinical Study

Nature's Medicinal Magic: Unveiling the Therapeutic Superiority of Nature-Derived Psilocybin

Published Mon, Mar 18 2024 8:05 PM UTC

In a breakthrough study published in the renowned journal Molecular Psychiatry, the comparative therapeutic benefits of nature-derived psilocybin and its synthetic counterpart have been explored. Through meticulous research, this study by Psyence Biomedical sheds light on the potential superiority of psilocybin derived from nature, providing a fascinating insight into the po...

Product Service News

Psyence Biomedical Granted Approval for Phase IIb Study on Psilocybin Treatment for Adjustment Disorder in Cancer Patients

Published Tue, Mar 12 2024 3:16 PM UTC

Psyence Group Inc. (CSE: PSYG), a leading clinical-stage life science biotechnology company specializing in the use of nature-derived psilocybin for mental health and wellbeing, is pleased to announce that its associate, Psyence Biomedical Ltd (NASDAQ: PBM), has received full approval from the Australian Health Research Ethics Committee (HREC) to initiate a Phase IIb study....

Stock Market Announcement

Psyence Biomedical: Pioneering Nature-Derived Psilocybin to Transform Mental Health Treatments

Published Tue, Mar 12 2024 11:00 AM UTC



In a recent press release, Psyence Biomedical Ltd., a leading clinical-stage life science biotechnology company, highlighted its recent progress and outlined key future milestones in pioneering the use of nature-derived psilocybin for mental health and wellbeing. Psyence Biomedical's groundbreaking research holds immense potential for revolutionizing mental health ...

Contract

Psyence Group's Spin-Out Marks Major Milestone in Psychedelic Medicine Industry

Published Mon, Mar 11 2024 11:00 AM UTC

Psyence Group, a leading innovator in the field of psychedelic medicine, recently provided a corporate update following the successful spin-out of its therapeutic division. The company closed the business combination of its subsidiary, Psyence Biomedical Ltd (PBM), with Newcourt Acquisition Corp, a special purpose acquisition company, ultimately resulting in the listing of P...

Clinical Study

Psyence Australia Receives HREC Approval for Phase IIb Study on Psilocybin's Efficacy in Palliative Care

Published Wed, Mar 6 2024 12:00 PM UTC

Psyence Biomedicals Subsidiary, Psyence Australia, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb StudyNEW YORK, March 06, 2024 - Psyence Biomedical Ltd (NASDAQ:PBM) (Psyence Biomed or the Company) is excited to announce a significant achievement for its wholly-owned subsidiary, Psyence Australia (Pty) Ltd (Psyence Australia). The Australian H...






 

Pacific Booker Minerals Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com